Life Stem Genetics Inc. (LIFS)

0.0016 0.0000 (0.00%) At close: 03:59PM EDT

Life Stem Genetics Inc.

433 North Camden Drive
Suite 400
Beverly Hills, CA 90210
United States
310-279-5234

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Gloria Simov	CEO, Pres & Director	5k	N/A	1986
Ms. Heather Sharp	Chief Financial Officer, Principal Accounting Officer, VP, Sec. and Director	N/A	N/A	1972
Dr. Vino Padayachee	Chairman & Bus. Devel. Director	N/A	N/A	1960

Amounts are as of 31 December 2013, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. Life Stem Genetics Inc. has a strategic collaborative agreement with American CryoStem Corporation. The company was founded in 2012 and is based in Beverly Hills, California.

Corporate governance

Life Stem Genetics Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.